PharmaVoice

Pharma Tech

RevMed’s pancreatic cancer drug breezes through with swift approval

Revolution Medicines’ breakthrough drug for pancreatic cancer was approved more than six months ahead of schedule.

Read Full Article

Pharma Tech

Metsera backers establish new biotech armed with China-licensed immunology asset

PHP and ARCH have established Sentivera, a biotech that now has an immunology licensing deal with China-based Haisco.

Read Full Article

Express Pharma

Aurigene enters into long-term manufacturing, supply partnership with a leading global pharma company

Aurigene Pharmaceutical Services (“Aurigene”), a wholly owned subsidiary of Dr. Reddy’s Laboratories announced a strategic, long-term Manufacturing and Supply Agreement (MSA) with a leading global pharmaceutical company for the commercial […] The post Aurigene enters into long-term manufacturing, supply partnership with a leading global pharma company appeared first on Express Pharma.

Read Full Article

Express Pharma

CBN and PHARMEXCIL sign MoU to regulate controlled substances in pharma exports

The Central Bureau of Narcotics (CBN), Department of Revenue, Ministry of Finance, and the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), set up by the Ministry of Commerce and Industry, […] The post CBN and PHARMEXCIL sign MoU to regulate controlled substances in pharma exports appeared first on Express Pharma.

Read Full Article

Pharma Tech

Jazz secures FDA approval for Ziihera in advanced HER2+ GEA

The FDA has approved two Jazz Pharmaceuticals regimens containing Ziihera for the first-line treatment of adults with unresectable, locally advanced or metastatic HER2-positive GEA.

Read Full Article

Featured promotional

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Aug 27, 2026, 2:25 AM

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

To ⁠date, the Trump administration has reached voluntary agreements with 17 pharmaceutical companies to slash medicine prices for the government's Medicaid program and for cash payers, including Pfizer, Eli Lilly and Amgen .

RevMed’s pancreatic cancer drug breezes through with swift approval

Metsera backers establish new biotech armed with China-licensed immunology asset

Aurigene enters into long-term manufacturing, supply partnership with a leading global pharma company

CBN and PHARMEXCIL sign MoU to regulate controlled substances in pharma exports

Jazz secures FDA approval for Ziihera in advanced HER2+ GEA

Featured promotional

Jeplus.in

Latest stories

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

RevMed’s pancreatic cancer drug breezes through with swift approval

Biohaven Licenses Kv7 Epilepsy Platform to SK Biopharmaceuticals in $795M Deal

Abbott Secures FDA Authorization for Libre Duo 10 Day, a Dual Glucose-Ketone Sensing Technology

Metsera backers establish new biotech armed with China-licensed immunology asset

Aurigene enters into long-term manufacturing, supply partnership with a leading global pharma company

Latest industry coverage

Countdown to BIOHK2026: World-Class Biotech Convention… - aapnews.aap.com.au

5th Circ. Upholds Drug Negotiations In Blow To Big Pharma - Law360

Site Management Organization Market - Future Market Insights

Mayne Pharma FY26 slides: margins expand despite revenue decline - Investing.com

Dimmer Outlook for Germany as a Research Hub - chemeurope.com

Kolon Life Science to Join Hong Kong Biotech Expo BIOHK2026 - Seoul Economic Daily

Embossed Aluminum Seals Market Growth to 2035 Driven by Injectable Biologics Scale-Up - News and Statistics - IndexBox

FDA approves new drug Rasonque to treat advanced pancreatic cancer - France 24

Generate Biomedicines Trades at 4.5x Book Value, Above Biotech Peers After 27.6% Rally - finance.biggo.com

Featured promotions

Jeplus.in